Q2 net bookings were €5.5 billion of which €2.3 billion was for EUV.
ASML expects Q3 2025 total net sales between €7.4 billion and €7.9 billion, and a gross margin between 50% and 52%
The company expects a full-year 2025 total net sales increase of around 15% relative to 2024, with a gross margin of around 52%
(Figures in millions of euros unless otherwise indicated) | Q1 2025 | Q2 2025 |
---|---|---|
Net sales | 7,742 | 7,692 |
…of which Installed Base Management sales 1 | 2,001 | 2,096 |
New lithography systems sold (units) | 73 | 67 |
Used lithography systems sold (units) | 4 | 9 |
Net bookings 2 | 3,936 | 5,541 |
Gross profit | 4,180 | 4,130 |
Gross margin (%) | 54.0 | 53.7 |
Net income | 2,355 | 2,290 |
EPS (basic; in euros) | 6.00 | 5.90 |
End-quarter cash and cash equivalents and short-term investments | 9,104 | 7,248 |
(1) Installed Base Management sales equals net service and field option sales.
(2) Net bookings include all system sales orders and inflation related adjustments, for which written authorizations have been accepted.
A complete summary of US GAAP Consolidated Statements of Operations is published on www.asml.com.
“Our second-quarter total net sales came in at €7.7 billion, at the top end of our guidance,” said CEO Christophe Fouquet (pictured), “the gross margin was 53.7%, above guidance, primarily driven by higher upgrade business and one-offs resulting in lower costs.
“We see continued progress in litho intensity, particularly in DRAM, and the introduction of the TWINSCAN NXE:3800E reinforces that momentum,” continuedvFouquet, “meanwhile, EUV adoption is advancing as planned, including High NA. This quarter, we shipped the first TWINSCAN EXE:5200B system.”
“Looking at 2026, we see that our AI customers’ fundamentals remain strong,” added Fouquet, “at the same time, we continue to see increasing uncertainty driven by macro-economic and geopolitical developments. Therefore, while we still prepare for growth in 2026, we cannot confirm it at this stage.”
“We expect third-quarter total net sales between €7.4 billion and €7.9 billion, with a gross margin between 50% and 52%,” concluded Fouquet, “we expect R&D costs of around €1.2 billion and SG&A costs of around €310 million. For the full year 2025, we expect a 15% increase in total net sales and a gross margin of around 52%,”